BEAMSTART Logo

Mediaiplus aims to be the Amazon of clinical trials

Korea Economic Daily LogoKorea Economic Daily4d ago

Mediaiplus aims to be the Amazon of clinical trials - Korea Economic Daily

Quick Summary:

Mediaiplus Inc., South Korea’s only provider of data analytics and contract research organization (CRO) matching services for clinical trials, envisions becoming Amazon.com in the clinical trials market.“Our goal is to be a global marketplace,” said Jung Jihee, chief executive and founder of Mediaiplus, during a recent interview with The Korea Economic Daily.“I want to make our platform a place where our clients can find everything they need to prepare clinical trials.” Founded in 2019, Mediaiplus is a Korean startup that provides vital data to prepare clinical trials and a matching service between a pharmaceutical company and a CRO.

With MediC, pharmaceutical and medical device-developing companies can obtain only relevant clinical trial data without worrying about any outdated data and expedite their trials.“Since 2019, we have built our accurate data assets using big data and AI technologies,” said Jung.“With AI, we mine, collect and clean data to turn them into actionable information … and provide insights.” It offers information about more than 500,000 clinical trial cases in real-time and AI-curated data on diseases, patents, research papers, drugs, companies, regulations and guidelines.

But we have such (validated) data in the region,” said Jung.“We also have been building clinical trial and researcher databases in Vietnam through an ODA program with KOICA and plan to offer similar services in other Asian countries.”The Asia Pacific region accounting for over half of the global population has emerged as a popular destination for clinical trials thanks to the region’s lower trial costs, access to large patient pools and friendly regulatory environments.


More Pictures

Mediaiplus aims to be the Amazon of clinical trials - Korea Economic Daily (Picture 1)Mediaiplus aims to be the Amazon of clinical trials - Korea Economic Daily (Picture 2)Mediaiplus aims to be the Amazon of clinical trials - Korea Economic Daily (Picture 3)Mediaiplus aims to be the Amazon of clinical trials - Korea Economic Daily (Picture 4)Mediaiplus aims to be the Amazon of clinical trials - Korea Economic Daily (Picture 5)

or

Article Details

Category: Economy

Markets:

Topics:

Source Website Secure: Yes (HTTPS)

News Sentiment: Positive

Fact Checked: Legitimate

Article Type: News Report

Published On: 2024-11-01 @ 14:08:55 (4 days ago)

News Timezone: GMT +8:00

News Source URL: kedglobal.com

Language: English

Article Length: 1206 words

Reading Time: 7 minutes read

Sentences: 45 lines

Sentence Length: 27 words per sentence (average)

Platforms: Desktop Web, Mobile Web, iOS App, Android App

Copyright Owner: © Korea Economic Daily

News ID: 23426947

View Article Analysis

About Korea Economic Daily

Korea Economic Daily Logo

Main Topics: Economy

Official Website: kedglobal.com

Update Frequency: 13 posts per day

Year Established: 1964

Headquarters: South Korea

News Last Updated: 4 hours ago

Coverage Areas: South Korea

Ownership: Independent Company

Publication Timezone: GMT +8:00

Content Availability: Worldwide

News Language: English

RSS Feed: Available (XML)

API Access: Available (JSON, REST)

Website Security: Secure (HTTPS)

Publisher ID: #91

Publisher Details

Frequently Asked Questions

How long will it take to read this news story?

The story "Mediaiplus aims to be the Amazon of clinical trials" has 1206 words across 45 sentences, which will take approximately 6 - 11 minutes for the average person to read.

Which news outlet covered this story?

The story "Mediaiplus aims to be the Amazon of clinical trials" was covered 4 days ago by Korea Economic Daily, a news publisher based in South Korea.

How trustworthy is 'Korea Economic Daily' news outlet?

Korea Economic Daily is a fully independent (privately-owned) news outlet established in 1964 that covers mostly economy news.

The outlet is headquartered in South Korea and publishes an average of 13 news stories per day.

It's most recent story was published 4 hours ago.

What do people currently think of this news story?

The sentiment for this story is currently Positive, indicating that people regard this as "good news".

How do I report this news for inaccuracy?

You can report an inaccurate news publication to us via our contact page. Please also include the news #ID number and the URL to this story.
  • News ID: #23426947
  • URL: https://beamstart.com/news/mediaiplus-aims-to-be-the-17307941026533

BEAMSTART

BEAMSTART is a global entrepreneurship community, serving as a catalyst for innovation and collaboration. With a mission to empower entrepreneurs, we offer exclusive deals with savings totaling over $1,000,000, curated news, events, and a vast investor database. Through our portal, we aim to foster a supportive ecosystem where like-minded individuals can connect and create opportunities for growth and success.

© Copyright 2024 BEAMSTART. All Rights Reserved.